Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04419402
Title Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer (ENZA-p)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Australian and New Zealand Urogenital and Prostate Cancer Trials Group

prostate adenocarcinoma

prostate cancer


Enzalutamide + lutetium Lu 177 vipivotide tetraxetan


Age Groups: senior | adult
Covered Countries

No variant requirements are available.